Gem Aromatics Limited
Gem Aromatics Limited (GEMAROMA) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
gemaromatics.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Sales | 88 Cr | 90 Cr | 79 Cr | 110 Cr | 99 Cr |
| Operating expenses (approx.) | 73 Cr | 86 Cr | 72 Cr | 95 Cr | 96 Cr |
| EBITDA | 15 Cr | 3 Cr | 7 Cr | 16 Cr | 3 Cr |
| OPM % | 17.0% | 3.4% | 8.9% | 14.2% | 3.3% |
| Other income | 1 Cr | 0.98 Cr | -2 Cr | 0.30 Cr | 0.16 Cr |
| Interest | 4 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr |
| Depreciation | 2 Cr | 3 Cr | 9 Cr | 9 Cr | 9 Cr |
| Profit before tax | 11 Cr | -3 Cr | -6 Cr | 4 Cr | -9 Cr |
| Tax % | 26.0% | -2.4% | 15.8% | 74.9% | 7.8% |
| Net profit | 8 Cr | -3 Cr | -5 Cr | 1 Cr | -8 Cr |
| EPS (₹) | ₹1.70 | ₹-0.04 | ₹-1.04 | ₹0.19 | ₹-1.56 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 366 Cr | Sign in for TTM |
| Operating expenses (approx.) | 326 Cr | Sign in for TTM |
| EBITDA | 41 Cr | Sign in for TTM |
| OPM % | 11.1% | Sign in for TTM |
| Other income | 0.90 Cr | Sign in for TTM |
| Interest | 13 Cr | Sign in for TTM |
| Depreciation | 23 Cr | Sign in for TTM |
| Profit before tax | 6 Cr | Sign in for TTM |
| Tax % | 77.6% | Sign in for TTM |
| Net profit | 1 Cr | Sign in for TTM |
| EPS (₹) | ₹0.28 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 10 Cr |
| Reserves | 439 Cr |
| Borrowings | 150 Cr |
| Other liabilities | 42 Cr |
| Total liabilities | 642 Cr |
| Fixed assets (net) | 243 Cr |
| CWIP | 6 Cr |
| Investments | 0 Cr |
| Loans & advances | 0.15 Cr |
| Inventories | 234 Cr |
| Trade receivables | 77 Cr |
| Cash & bank | 8 Cr |
| Other assets | 74 Cr |
| Total assets | 642 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | 30 Cr |
| Cash from investing | -101 Cr |
| Cash from financing | 78 Cr |
| Net cash flow | 5 Cr |
| Free cash flow (OCF − Capex) | -66 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2026 |
|---|---|
| ROCE % | 3.2% |
| ROE % | 0.3% |
| Debtor days | 76 |
| Inventory days | 263 |
| Days payable | 22 |
| Cash conversion cycle | 317 |
| Debt / equity | 0.33 |
| Current ratio | 2.16 |
| Net debt / EBITDA | 3.48 |
Compare with peers
Loading peers…